The business impact of an integrated continuous biomanufacturing platform for recombinant protein production.

Walther, Jason; Godawat, Rahul; Hwang, Chris; Abe, Yuki; Sinclair, Andrew; Konstantinov, Konstantin

Walther, Jason; Godawat, Rahul; Hwang, Chris; Abe, Yuki; Sinclair, Andrew; Konstantinov, Konstantin.

Afiliação

Walther J; Late Stage Process Development, BioRealization, R&D, Sanofi, Framingham, MA 01701, USA.
Godawat R; Late Stage Process Development, BioRealization, R&D, Sanofi, Framingham, MA 01701, USA. Electronic address: rahul.godawat@sanofi.com.
Hwang C; Late Stage Process Development, BioRealization, R&D, Sanofi, Framingham, MA 01701, USA.
Abe Y; Biopharm Services, Chesham, HP51SD, UK.
Sinclair A; Biopharm Services, Chesham, HP51SD, UK.
Konstantinov K; Late Stage Process Development, BioRealization, R&D, Sanofi, Framingham, MA 01701, USA.

J Biotechnol ; 213: 3-12, 2015 Nov 10.

Article em En | MEDLINE | ID: mdl-26014522

Assuntos

Indústria Farmacêutica/economia; Modelos Teóricos; Proteínas Recombinantes/economia; Reatores Biológicos/economia; Biotecnologia/economia; Comércio; Método de Monte Carlo; Risco

Palavras-chave

Biosolve; Continuous bioprocessing; Continuous capture; Cost of goods; Net present value; Perfusion cell culture

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Indústria Farmacêutica / Modelos Teóricos Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google